CTIS2022-500714-25-01招募中1 期
Congenital CMV treated with valaciclovir during pregnancy: a prospective cohort study
Z Leuven0 个研究点目标入组 112 人开始时间: 2023年7月5日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- In Utero 至 64（—）
入选标准
- •Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures, 18 years or older, Proven first trimester primary CMV infection
排除标准
- •Participant has a history of kidney function problems, liver function problems, immunocomprimised, Any disorder, which in the Investigator’s opinion might jeopardise the participant’s safety or compliance with the protocol, Any prior or concomitant treatment(s) that might jeopardise the participant’s safety or that would compromise the integrity of the Trial, Participation in an interventional Trial with an investigational medicinal product (IMP) or device
研究者
相似试验
进行中（未招募）
不适用
Efficacy of antiviral treatment of congenital cytomegalovirus in a randomized controlled trialCongenital cytomegalovirus infection.Sensorineural Hearingloss.MedDRA version: 14.1Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-005378-44-NLMC
已完成
4 期
Valganciclovir Dosing in Pediatric Solid Organ Transplant RecipientsInfection in Solid Organ Transplant RecipientsNCT02503982Rabin Medical Center13
进行中（未招募）
1 期
Traitement prénatal de l'infection congénitale à cytomégalovirus par le letermovir randomisé contre le valaciclovirStep 1: Maternal administration of 1 tablet of Letermovir (240 mg or 480 mg /day) during 3 days before TOPStep 2: Maternal daily administration of 240 or 480 milligrams of letermovir (1x240 mg-tablets) or (1x480 mg-tablets) (the dose will be choosen depending on the results obtained on step 1) up-until delivery or TOPEUCTR2020-002924-35-FRASSISTANCE PUBLIQUE HÔPITAUX DE PARIS56
已完成
2 期
TAMOVALCIR in Allogenic Hematopoietic Progenitors TransplantCytomegalovirus InfectionNCT00386412PETHEMA Foundation132
终止
3 期
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled TrialSensorineural Hearing LossCongenital Cytomegalovirus InfectionNCT01655212Dr. Ann C.T.M. Vossen2